All long Covid articles
-
NewsMcMaster leads Canada’s first-ever guidelines for Post COVID-19 Condition
A team of experts from McMaster University has led the creation of Canada’s first-ever comprehensive guidelines for diagnosing, managing, preventing, and treating post COVID-19 condition (PCC), more commonly known as long COVID.
-
NewsCOVID-19 discovery opens door to new treatments for chronic lung problems
A discovery was made to understand how severe viral infections, like COVID-19 and flu could destroy the ability of immune cells to repair the tissue damage in lungs, causing long COVID and other chronic lung diseases.
-
NewsSymptoms of long-COVID can last up to two years after infection with COVID-19
According to a study of the COVICAT cohort, almost one in four people infected with SARS-CoV-2 suffered from long-COVID. In more than half of them the symptoms persisted for two years.
-
NewsLung abnormalities seen in children and teens with long COVID
An advanced type of MRI uncovers significant lung abnormalities in children and adolescents with long COVID, according to a new study. PREFUL MRI doesn’t require the use of radiation or intravenous contrast agents and can be done while the patient breathes freely.
-
NewsWhite blood cell count could predict severity of COVID-19 symptoms
A new study suggests that a readily available and inexpensive clinical marker of inflammation could be key in predicting debilitating COVID outcomes in postmenopausal women.
-
NewsScientists discover molecular ‘fingerprint’ of Long Covid in children’s blood
A new study has highlighted the molecular signature of Long Covid in plasma in paediatric age and used an AI tool capable of making the diagnosis based on the results of the blood sample with 93% accuracy.
-
NewsNew review highlights variant-specific differences in long COVID
Alpha and Delta variants have been linked to a higher prevalence of cardiopulmonary symptoms, such as breathlessness and chest pain, while Omicron infections show fewer severe cardiopulmonary effects but relatively higher incidences of fatigue and brain fog.
-
NewsSARS-CoV-2 ‘steals’ our proteins to protect itself from the immune system
Researchers at the Medical University of Vienna and the Medical University of Innsbruck discovered that SARS-CoV-2 hijacks three important host proteins that dampen the activity of the complement system, a key component of early antiviral immunity. This significantly impairs viral clearance which may affect the course of ...
-
NewsScientists developing microchips with brain and lung tissue to study viral neuroinflammation
Researchers will use tissue-on-chip technology to understand and treat neurological symptoms such as brain fog associated with respiratory diseases like influenza.
-
NewsState-of-the-art centre for patients with complex conditions including Lyme disease and long COVID
New state-of-the-art US centre will support patients recovering from complex chronic illnesses such as long Lyme disease and long COVID.
-
NewsStudy finds persistent infection could explain long COVID in some people
Researchers found people with wide-ranging long COVID symptoms were twice as likely to have SARS-CoV-2 proteins in their blood, compared to those without long COVID symptoms.
-
NewsStudy sheds light on how virus-fighting cells develop during long Covid
A new long-term study into long COVID has investigated how a certain population of white blood cells, called memory T cells, are established and develop as part of the body’s defense to fight off the disease.
-
NewsImmune cells prevent lung healing after viral infection
Investigators have discovered a pathway by which immune cells prevent the lungs’ protective barrier from healing after viral infections like COVID-19.
-
NewsLargest study of its kind finds common lab tests aren’t reliable for diagnosing Long COVID
A new study found that most routine laboratory tests are not reliable for diagnosing Long Covid, also known as Post-Acute Sequelae of SARS-CoV-2 infection (PASC).
-
NewsLong Covid continues to evade diagnosis
A national cohort study of adult US participants with and without prior SARS-CoV-2 infection found that there are no objective tests to accurately diagnose post-acute sequelae of SARS-CoV-2 infection (PASC), also known as Long Covid.
-
NewsScientists probe molecular cause of COVID-19 related diarrhea, revealing potential treatments
Working with human stem cells that form a kind of ’mini intestine-in-a-dish’, scientists say they have found several molecular mechanisms for COVID-19-related diarrhea, suggesting potential ways to control it.
-
NewsNew study highlights scale and impact of long COVID
A wide range of biological mechanisms are involved in long Covid, including persistence of the original virus in the body, disruption of the normal immune response, and microscopic blood clotting, even in some people who had only mild initial infections.
-
NewsFinding a solution for long COVID, one cell type at a time
A 2022 study suggesting that blocking a single molecule could protect against severe illness in COVID-19 has led to a $15 million federal grant supporting a comprehensive effort to learn more – with finding a solution to long COVID at the center of the new research.
-
NewsReinfections from the virus that causes COVID-19 likely have similar severity to original infection
Researchers have found that severe infections from the virus that causes COVID-19 tend to foreshadow similar severity of infection the next time a person contracts the disease.
-
NewsScientists uncover risk factors for long Covid
A study has found that people with a milder Covid-19 infection—including those who were vaccinated against SARS-CoV-2 and those who were infected with an Omicron variant—were more likely to recover quickly.